IL27 and atherosclerosis: IL-27 signaling is involved in other pathological conditions such as atherosclerosis, non-small cell lung cancer (NSCLC) and other inflammatory diseases but the dynamics of IL-27 subunit coexpression in human tissues in the setting of health and viral infections remains scarce (76–80).